For Pfizer vaccines to be administered to the 12-15 age group, the meeting of the Italian drug agency on Monday. After the green light from the European Medicines Agency (Ema) for the Pfizer-BionTech vaccine against Covid-19 for the 12-15 year old age group, the technical-scientific Commission of Aifa, the Italian drug agency, will meet on Monday afternoon – to what is learned – to examine the dossier on the authorization in Italy. Practically discounted authorization, as anticipated in the morning by the president of Aifa, Giorgio Palù. Read also Meanwhile, as regards the green light of the Ema, the doses will be two, with the second dose administered 21 days after the first. “The vaccine response in 12-15 year olds is like that of adults or better,” explains the European Medicines Agency Ema. This is the first Covid vaccine approved for children and young people of this age group in the EU.The use of the Comirnaty vaccine in children aged 12-15 will be the same as in people aged 16 and over , for which it is already authorized. It is given in two doses, three weeks apart. “We have data showing that Pfizer / BioNTech’s ‘anti-Covid vaccine’ is safe even in the age of 12-15 years and showing that the immune response in this group is similar or even better than what we see in young adults “said Marco Cavaleri, head of Vaccines and Therapeutic Products for Covid-19 of the European Medicines Agency (EMA). Looking at the trial data, it emerges that “the vaccine is highly effective in protecting and preventing disease” in this age group.